Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, ...

Cognitive and behavioral techniques can improve physical function and overall well-being in patients with long COVID.

The rate of frailty among patients with multiple sclerosis (MS) ranges from 17% to 66% among ambulatory patients, and frailty ...

Among the most-read coverage for the annual meeting were presentations on the potential and costs of cell and gene therapies, ...

EDO51, an investigational therapy for Duchenne muscular dystrophy (DMD), and is still ongoing in the United Kingdom.

HIV stigma, rooted in the 1980s, persists, affecting care and prevention efforts despite treatment advancements. Stigma ...

Low lung cancer screening awareness in underserved communities is linked to barriers like education and healthcare access, ...

Based on their findings, the researchers suggest the integration of automated measures to identify interventricular septal ...

From imaging innovations to new treatment approvals, 2024 brought advancements in Duchenne muscular dystrophy care and ...

Annual Meeting & Exposition provides insights into the prognostic utility of geriatric assessment tools and their role in ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Compared with originator bevacizumab, the biosimilar version of bevacizumab had equal efficacy when used to treat metastatic ...